Manulife (Manufacturers Life Insurance)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5M | Sell |
41,501
-14,860
| -26% | -$8.37M | 0.02% | 609 |
|
|
2026
Q1 | $33.4M | Sell |
56,361
-5,339
| -9% | -$2.66M | 0.03% | 470 |
|
|
2025
Q4 | $30.3M | Sell |
61,700
-591
| -0.9% | -$275K | 0.02% | 524 |
|
|
2025
Q3 | $26.1M | Buy |
62,291
+5,168
| +9% | +$1.74M | 0.02% | 564 |
|
|
2025
Q2 | $16.4M | Sell |
57,123
-14,638
| -20% | -$4.37M | 0.01% | 660 |
|
|
2025
Q1 | $22.1M | Sell |
71,761
-51,556
| -42% | -$17.7M | 0.02% | 573 |
|
|
2024
Q4 | $43.5M | Buy |
123,317
+25,848
| +27% | +$9.5M | 0.04% | 396 |
|
|
2024
Q3 | $34.9M | Sell |
97,469
-1,314
| -1% | -$444K | 0.03% | 460 |
|
|
2024
Q2 | $31.5M | Buy |
98,783
+26,840
| +37% | +$7.1M | 0.03% | 471 |
|
|
2024
Q1 | $16.5M | Buy |
71,943
+32,150
| +81% | +$7.25M | 0.02% | 679 |
|
|
2023
Q4 | $8.75M | Sell |
39,793
-763
| -2% | -$176K | 0.01% | 908 |
|
|
2023
Q3 | $9.16M | Buy |
40,556
+5,400
| +15% | +$1.24M | 0.01% | 854 |
|
|
2023
Q2 | $7.76M | Sell |
35,156
-341
| -1% | -$75.5K | ﹤0.01% | 890 |
|
|
2023
Q1 | $7.95M | Sell |
35,497
-1,306
| -4% | -$322K | ﹤0.01% | 887 |
|
|
2022
Q4 | $10.2M | Sell |
36,803
-71
| -0.2% | -$17.9K | 0.01% | 788 |
|
|
2022
Q3 | $7.72M | Sell |
36,874
-4,650
| -11% | -$1.04M | 0.01% | 878 |
|
|
2022
Q2 | $9.79M | Buy |
41,524
+3,393
| +9% | +$690K | 0.01% | 836 |
|
|
2022
Q1 | $6.84M | Sell |
38,131
-12,718
| -25% | -$2.42M | ﹤0.01% | 1031 |
|
|
2021
Q4 | $11K | Sell |
50,849
-761
| -1% | -$149K | 0.01% | 902 |
|
|
2021
Q3 | $9.53M | Buy |
51,610
+2,552
| +5% | +$503K | 0.01% | 955 |
|
|
2021
Q2 | $8.8M | Sell |
49,058
-928
| -2% | -$177K | 0.01% | 1013 |
|
|
2021
Q1 | $8.36M | Sell |
49,986
-3,365
| -6% | -$561K | 0.01% | 1030 |
|
|
2020
Q4 | $8.1M | Sell |
53,351
-4,860
| -8% | -$638K | 0.01% | 997 |
|
|
2020
Q3 | $5.88M | Sell |
58,211
-793
| -1% | -$87K | 0.01% | 1045 |
|
|
2020
Q2 | $7.08M | Sell |
59,004
-3,851
| -6% | -$433K | 0.01% | 945 |
|
|
2020
Q1 | $5.96M | Buy |
62,855
+1,271
| +2% | +$121K | 0.01% | 958 |
|
|
2019
Q4 | $5.42M | Sell |
61,584
-3,538
| -5% | -$311K | 0.01% | 1156 |
|
|
2019
Q3 | $5.26M | Sell |
65,122
-6,341
| -9% | -$511K | 0.01% | 1137 |
|
|
2019
Q2 | $5.58M | Buy |
71,463
+3
| +0% | +$281 | 0.01% | 1132 |
|
|
2019
Q1 | $8.39M | Sell |
71,460
-2,077
| -3% | -$242K | 0.01% | 958 |
|
|
2018
Q4 | $8.01M | Buy |
73,537
+1,215
| +2% | +$141K | 0.01% | 908 |
|
|
2018
Q3 | $9.25M | Buy |
72,322
+2,823
| +4% | +$349K | 0.01% | 917 |
|
|
2018
Q2 | $7.86M | Buy |
69,499
+178
| +0.3% | +$19.6K | 0.01% | 1030 |
|
|
2018
Q1 | $7.79M | Sell |
69,321
-2,396
| -3% | -$304K | 0.01% | 1029 |
|
|
2017
Q4 | $10.6M | Buy |
71,717
+7,746
| +12% | +$985K | 0.01% | 841 |
|
|
2017
Q3 | $7.5M | Sell |
63,971
-2,401
| -4% | -$307K | 0.01% | 969 |
|
|
2017
Q2 | $8.61M | Buy |
66,372
+1,242
| +2% | +$155K | 0.01% | 900 |
|
|
2017
Q1 | $8.82M | Buy |
65,130
+7,042
| +12% | +$1.07M | 0.01% | 873 |
|
|
2016
Q4 | $8.33M | Sell |
58,088
-1,783
| -3% | -$228K | 0.01% | 823 |
|
|
2016
Q3 | $7.07M | Sell |
59,871
-769
| -1% | -$92.4K | 0.01% | 869 |
|
|
2016
Q2 | $6.42M | Buy |
60,640
+462
| +0.8% | +$51.5K | 0.01% | 898 |
|
|
2016
Q1 | $6.62M | Buy |
60,178
+593
| +1% | +$75K | 0.01% | 894 |
|
|
2015
Q4 | $9.33K | Sell |
59,585
-18
| -0% | -$2.62K | 0.01% | 697 |
|
|
2015
Q3 | $7.82K | Sell |
59,603
-2,313
| -4% | -$371K | 0.01% | 778 |
|
|
2015
Q2 | $10.8K | Buy |
61,916
+1,642
| +3% | +$295K | 0.01% | 663 |
|
|
2015
Q1 | $10.4K | Sell |
60,274
-406
| -0.7% | -$61.9K | 0.01% | 677 |
|
|
2014
Q4 | $7.86K | Sell |
60,680
-1,641
| -3% | -$211K | 0.01% | 758 |
|
|
2014
Q3 | $8.02K | Buy |
62,321
+5,458
| +10% | +$563K | 0.01% | 743 |
|
|
2014
Q2 | $5.03M | Buy |
56,863
+14,452
| +34% | +$1.39M | 0.01% | 1006 |
|
|
2014
Q1 | $6.4K | Sell |
42,411
-25,893
| -38% | -$2.65M | 0.01% | 898 |
|
|
2013
Q4 | $7.72K | Buy |
68,304
+7,496
| +12% | +$676K | 0.01% | 772 |
|
|
2013
Q3 | $4.79K | Sell |
60,808
-302
| -0.5% | -$22.1K | 0.01% | 972 |
|
|
2013
Q2 | $4.02M | Buy |
+61,110
| New | +$3.94M | 0.01% | 978 |
|
Other funds holding UTHR
ACA
JT
Manulife (Manufacturers Life Insurance)'s UTHR Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its United Therapeutics (UTHR) stake by 26% in Q2 2026, selling an estimated $8.37M and leaving 41,501 shares worth $22.5M. The position accounts for 0.02% of the portfolio, ranked #609.
Manulife (Manufacturers Life Insurance) first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.5M in Q4 2024. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 41,501 shares of United Therapeutics worth $22.5M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) sold 14,860 United Therapeutics shares in Q2 2026, an estimated $8.37M.
- United Therapeutics made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #609 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Manulife (Manufacturers Life Insurance)'s United Therapeutics position peaked at $43.5M in Q4 2024.
- 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.